Hyloris Pharmaceuticals Investor Relations Material

Hyloris Pharmaceuticals SA is a Belgian specialty pharmaceutical company that develops reformulated and repurposed medicines. Its portfolio focuses on improving existing drugs to address unmet clinical needs across hospital and emergency care settings. The company engages in regulatory development and commercialization through partnerships. It is headquartered in Liège, Belgium, and its shares are listed on the EURONEXT Brussels.